$SVRA
Savara Inc

2019 Q3 Form 10-Q Financial Statement

#000156459019041725 Filed on November 07, 2019

View on sec.gov

Income Statement

Concept 2019 Q3 2018 Q3 2018 Q2
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $2.810M $3.150M $2.490M
YoY Change -10.79% 126.62% -16.72%
% of Gross Profit
Research & Development $9.575M $9.509M $9.270M
YoY Change 0.69% 91.48% 122.62%
% of Gross Profit
Depreciation & Amortization $230.0K $130.0K $153.0K
YoY Change 76.92% 42.86% 68.13%
% of Gross Profit
Operating Expenses $12.44M $12.78M $11.91M
YoY Change -2.68% 95.38% 27.44%
Operating Profit -$12.44M -$12.78M -$11.91M
YoY Change -2.68% 95.38% 27.43%
Interest Expense $5.000K $111.0K $113.0K
YoY Change -95.5% -59.93% -78.1%
% of Operating Profit
Other Income/Expense, Net $39.00K $224.0K $313.0K
YoY Change -82.59% -111.9%
Pretax Income -$12.40M -$12.56M -$11.59M
YoY Change -1.25% 81.14% -3.17%
Income Tax $0.00 $0.00 -$277.0K
% Of Pretax Income
Net Earnings -$12.40M -$12.56M -$11.59M
YoY Change -1.25% 84.25% 0.77%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$297.1K -$364.3K -$368.8K
COMMON SHARES
Basic Shares Outstanding 41.20M
Diluted Shares Outstanding

Balance Sheet

Concept 2019 Q3 2018 Q3 2018 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $106.3M $112.0M $74.80M
YoY Change -5.09% 110.13% 22.42%
Cash & Equivalents $17.79M $24.95M $23.60M
Short-Term Investments $88.50M $87.10M $51.20M
Other Short-Term Assets $700.0K $1.600M $1.500M
YoY Change -56.25% -11.11% 15.38%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $108.3M $114.7M $77.40M
YoY Change -5.62% 106.75% 21.51%
LONG-TERM ASSETS
Property, Plant & Equipment $1.200M $605.0K $700.0K
YoY Change 98.35% 0.83% 0.0%
Goodwill $19.43M $26.96M
YoY Change -27.93%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.651M $1.292M $1.200M
YoY Change 27.79% 29.2% 1100.0%
Total Long-Term Assets $32.33M $40.38M $40.50M
YoY Change -19.94% -36.31% -34.75%
TOTAL ASSETS
Total Short-Term Assets $108.3M $114.7M $77.40M
Total Long-Term Assets $32.33M $40.38M $40.50M
Total Assets $140.6M $155.1M $117.9M
YoY Change -9.34% 30.47% -6.26%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.903M $3.240M $2.500M
YoY Change -10.4% 90.59% 29.4%
Accrued Expenses $5.388M $3.912M $2.800M
YoY Change 37.73% -4.59% -48.97%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $4.100M $2.200M
YoY Change 1266.67% 214.29%
Total Short-Term Liabilities $8.300M $11.20M $7.500M
YoY Change -25.89% 83.61% -7.84%
LONG-TERM LIABILITIES
Long-Term Debt $25.00M $11.40M $13.10M
YoY Change 119.3% -24.0% -12.08%
Other Long-Term Liabilities $572.0K $12.20M $12.00M
YoY Change -95.31% 2.52% 1.69%
Total Long-Term Liabilities $572.0K $23.60M $25.10M
YoY Change -97.58% -12.27% -5.99%
TOTAL LIABILITIES
Total Short-Term Liabilities $8.300M $11.20M $7.500M
Total Long-Term Liabilities $572.0K $23.60M $25.10M
Total Liabilities $33.83M $37.30M $35.20M
YoY Change -9.32% -15.69% -23.48%
SHAREHOLDERS EQUITY
Retained Earnings -$176.2M -$106.6M
YoY Change
Common Stock $283.2M $188.9M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $106.8M $117.9M $82.71M
YoY Change
Total Liabilities & Shareholders Equity $140.6M $155.1M $117.9M
YoY Change -9.33% 30.45% -6.25%

Cashflow Statement

Concept 2019 Q3 2018 Q3 2018 Q2
OPERATING ACTIVITIES
Net Income -$12.40M -$12.56M -$11.59M
YoY Change -1.25% 84.25% 0.77%
Depreciation, Depletion And Amortization $230.0K $130.0K $153.0K
YoY Change 76.92% 42.86% 68.13%
Cash From Operating Activities -$11.42M -$8.760M -$10.35M
YoY Change 30.37% 6.31% 34.77%
INVESTING ACTIVITIES
Capital Expenditures -$10.00K -$10.00K -$50.00K
YoY Change 0.0%
Acquisitions
YoY Change
Other Investing Activities $6.600M -$35.70M $11.88M
YoY Change -118.49% 6.76% 245.35%
Cash From Investing Activities $6.590M -$35.71M $11.83M
YoY Change -118.45% 6.79% 243.9%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 5.710M 45.81M 20.00K
YoY Change -87.54% 10553.49% -99.96%
NET CHANGE
Cash From Operating Activities -11.42M -8.760M -10.35M
Cash From Investing Activities 6.590M -35.71M 11.83M
Cash From Financing Activities 5.710M 45.81M 20.00K
Net Change In Cash 880.0K 1.340M 1.500M
YoY Change -34.33% -103.25% -97.04%
FREE CASH FLOW
Cash From Operating Activities -$11.42M -$8.760M -$10.35M
Capital Expenditures -$10.00K -$10.00K -$50.00K
Free Cash Flow -$11.41M -$8.750M -$10.30M
YoY Change 30.4% 6.19% 34.11%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
152287000
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
35146096
CY2019Q3 us-gaap Goodwill
Goodwill
19432000
CY2018Q4 us-gaap Goodwill
Goodwill
26918000
CY2019Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1651000
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
131000
CY2019Q3 us-gaap Assets
Assets
140628000
CY2018Q4 us-gaap Assets
Assets
152287000
CY2019Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
2903000
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3879000
CY2019Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5388000
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3375000
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
7254000
CY2018Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
24530000
CY2018Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
12214000
CY2019Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
572000
CY2018Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
70000
CY2019Q3 us-gaap Liabilities
Liabilities
33825000
CY2018Q4 us-gaap Liabilities
Liabilities
44068000
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
36000
CY2018Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
237702000
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
200000
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-129719000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
108219000
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
35146096
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
30058000
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
21692000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-46454000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-55557000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4555000
us-gaap Net Income Loss
NetIncomeLoss
-46454000
CY2018Q3 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
9509000
CY2019Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2811000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
387000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1062000
us-gaap Operating Expenses
OperatingExpenses
47516000
us-gaap Operating Income Loss
OperatingIncomeLoss
-47516000
us-gaap Operating Expenses
OperatingExpenses
56797000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
16000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
167000
svra Tax Credit Income
TaxCreditIncome
1133000
CY2018Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
224000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
253000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-106000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
87000
svra Tax Credit Income
TaxCreditIncome
1311000
svra Change In Fair Value Of Financial Instruments Net Of Contingent Consideration
ChangeInFairValueOfFinancialInstrumentsNetOfContingentConsideration
-254000
svra Change In Fair Value Of Financial Instruments Net Of Contingent Consideration
ChangeInFairValueOfFinancialInstrumentsNetOfContingentConsideration
-52000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1240000
CY2019Q3 us-gaap Common Stock Value
CommonStockValue
42000
CY2019Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
283170000
CY2019Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
41208261
CY2019Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-236000
CY2019Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-176173000
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
106803000
CY2019Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
41208261
CY2019Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
140628000
CY2019Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2019Q3 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
9575000
us-gaap Operating Income Loss
OperatingIncomeLoss
-56797000
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
-12560000
CY2018Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.36
CY2018Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
34483563
CY2018Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-105000
CY2018Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
13000
CY2018Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-12652000
CY2019Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-225000
CY2019Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
26000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-12112000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
101804000
CY2019Q3 us-gaap Operating Expenses
OperatingExpenses
12442000
CY2018Q3 us-gaap Operating Expenses
OperatingExpenses
12784000
CY2019Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
39000
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-12442000
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-12784000
CY2019Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
5000
CY2018Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
111000
CY2019Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
116000
CY2018Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-7000
CY2019Q3 svra Tax Credit Income
TaxCreditIncome
54000
CY2018Q3 svra Tax Credit Income
TaxCreditIncome
110000
CY2019Q3 svra Change In Fair Value Of Financial Instruments Net Of Contingent Consideration
ChangeInFairValueOfFinancialInstrumentsNetOfContingentConsideration
-136000
CY2018Q3 svra Change In Fair Value Of Financial Instruments Net Of Contingent Consideration
ChangeInFairValueOfFinancialInstrumentsNetOfContingentConsideration
10000
CY2019Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.30
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-12403000
CY2018Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-12560000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-12403000
CY2019Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
41727259
CY2019Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-436000
CY2019Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-12000
CY2019Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-12851000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
26000
us-gaap Profit Loss
ProfitLoss
-51002000
CY2019Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
45000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
119309000
CY2018Q1 svra Issuance Of Common Stock Upon At The Market Offering Net
IssuanceOfCommonStockUponAtTheMarketOfferingNet
493000
CY2018Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3000
CY2018Q1 svra Issuance Of Common Stock Upon Exercise Of Warrants Amount
IssuanceOfCommonStockUponExerciseOfWarrantsAmount
18000
CY2018Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
412000
CY2018Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
341000
CY2018Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-24000
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-26848000
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
93704000
CY2018Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
30000
us-gaap Net Income Loss
NetIncomeLoss
-51002000
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.20
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.57
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
38749002
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
32423510
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-570000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-620000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
134000
CY2019Q1 svra Issuance Of Common Stock Upon At The Market Offering Net
IssuanceOfCommonStockUponAtTheMarketOfferingNet
4890000
CY2019Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
6000
CY2019Q2 svra Issuance Of Common Stock Upon At The Market Offering Net
IssuanceOfCommonStockUponAtTheMarketOfferingNet
19037000
CY2019Q2 svra Issuance Of Common Stock Upon Settlement Of Contingent Liability
IssuanceOfCommonStockUponSettlementOfContingentLiability
12478000
CY2019Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
62000
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1146000
CY2019Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
91000
CY2019Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
120000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-21939000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
112799000
CY2019Q3 svra Issuance Of Common Stock Upon At The Market Offering Net
IssuanceOfCommonStockUponAtTheMarketOfferingNet
5664000
CY2018Q2 svra Issuance Of Common Stock Upon Exercise Of Warrants Amount
IssuanceOfCommonStockUponExerciseOfWarrantsAmount
1000
CY2018Q2 us-gaap Stock Issued During Period Value Purchase Of Assets
StockIssuedDuringPeriodValuePurchaseOfAssets
995000
CY2018Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
392000
CY2018Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-856000
CY2018Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
37000
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-11594000
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
82709000
CY2018Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
45792000
CY2018Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
17000
CY2018Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1988000
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
117854000
us-gaap Profit Loss
ProfitLoss
-46454000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
772000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
387000
svra Change In Fair Value Of Financial Instruments
ChangeInFairValueOfFinancialInstruments
-254000
svra Change In Fair Value Of Financial Instruments
ChangeInFairValueOfFinancialInstruments
-52000
svra Change In Fair Value Of Contingent Consideration
ChangeInFairValueOfContingentConsideration
264000
svra Change In Fair Value Of Contingent Consideration
ChangeInFairValueOfContingentConsideration
131000
svra Paid In Kind Interest Income Expense
PaidInKindInterestIncomeExpense
42000
svra Paid In Kind Interest Income Expense
PaidInKindInterestIncomeExpense
83000
us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
995000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
432000
svra Accretion On Discount To Short Term Investments
AccretionOnDiscountToShortTermInvestments
1004000
svra Accretion On Discount To Short Term Investments
AccretionOnDiscountToShortTermInvestments
546000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
332000
us-gaap Share Based Compensation
ShareBasedCompensation
3292000
us-gaap Share Based Compensation
ShareBasedCompensation
2792000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-4555000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-394000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
424000
svra Increase Decrease In Noncurrent Assets
IncreaseDecreaseInNoncurrentAssets
672000
svra Increase Decrease In Accounts Payable And Accrued Expenses And Other Current Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedExpensesAndOtherCurrentLiabilities
429000
svra Increase Decrease In Accounts Payable And Accrued Expenses And Other Current Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedExpensesAndOtherCurrentLiabilities
1391000
svra Increase Decrease In Long Term Liabilities
IncreaseDecreaseInLongTermLiabilities
-179000
svra Increase Decrease In Long Term Liabilities
IncreaseDecreaseInLongTermLiabilities
-23000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-35177000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-28782000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
138000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
81000
svra Payments For Proceeds From Available For Sale Securities Debt
PaymentsForProceedsFromAvailableForSaleSecuritiesDebt
104204000
svra Payments For Proceeds From Available For Sale Securities Debt
PaymentsForProceedsFromAvailableForSaleSecuritiesDebt
88104000
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
89200000
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
64346000
us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
14131000
us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
9351000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1011000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-14488000
svra Proceeds From Issuance Of Common Stock Upon Exercise Of Warrants
ProceedsFromIssuanceOfCommonStockUponExerciseOfWarrants
19000
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
45792000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
29591000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
493000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
111000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
50000
us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
42000
us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
257000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
29660000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
46097000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
12000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-2000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-6516000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2825000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
24301000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
22121000
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
17785000
CY2018Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
24946000
svra Common Stock Issued For In Process Research And Development Net
CommonStockIssuedForInProcessResearchAndDevelopmentNet
995000
svra Non Cash Settlement Of Contingent Consideration
NonCashSettlementOfContingentConsideration
12478000
us-gaap Interest Paid Net
InterestPaidNet
1596000
us-gaap Interest Paid Net
InterestPaidNet
1038000
us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Use of Estimates </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements in conformity with U.S. GAAP requires the Company to make certain estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Management&#8217;s estimates include those related to the accrual of research and development and general and administrative costs, certain financial instruments recorded at fair value, stock-based compensation, and the valuation allowance for deferred tax assets. The Company bases its estimates on historical experience and on various other market-specific and relevant assumptions that it believes to be reasonable under the circumstances. Accordingly, actual results could be materially different from those estimates. </p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="margin-bottom:0pt;margin-top:8pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Concentration of Credit Risk </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments, which potentially subject the Company to concentrations of credit risk, consist principally of cash and cash equivalents and foreign exchange derivatives not designated as hedging. The Company places its cash and cash equivalents with a limited number of high-quality financial institutions and at times may exceed the amount of insurance provided on such deposits. </p>
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2019Q3 svra Deposits And Other Assets Current
DepositsAndOtherAssetsCurrent
267000
CY2018Q4 svra Deposits And Other Assets Current
DepositsAndOtherAssetsCurrent
107000
CY2019Q3 svra Accrued Contracted Research And Development Costs
AccruedContractedResearchAndDevelopmentCosts
3210000
CY2018Q4 svra Accrued Contracted Research And Development Costs
AccruedContractedResearchAndDevelopmentCosts
2044000
CY2019Q3 svra Accrued General And Administrative Costs
AccruedGeneralAndAdministrativeCosts
301000
CY2018Q4 svra Accrued General And Administrative Costs
AccruedGeneralAndAdministrativeCosts
371000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0
us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
us-gaap:ProductMember
svra Liquid Investments Maturity Period
LiquidInvestmentsMaturityPeriod
three months or less
svra In Process Research And Development Decrease
InProcessResearchAndDevelopmentDecrease
600000
us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
0
svra Date Of Agreement
DateOfAgreement
2018-10-08
us-gaap Long Term Purchase Commitment Amount
LongTermPurchaseCommitmentAmount
11267000
CY2019Q3 svra Contingent Milestones Or Co Marketing Commitments Incurred
ContingentMilestonesOrCoMarketingCommitmentsIncurred
0
CY2019Q3 svra Contingent Milestones Or Co Marketing Commitments Remunerated
ContingentMilestonesOrCoMarketingCommitmentsRemunerated
0
CY2019Q3 svra Contingent Milestones Or Co Marketing Commitments Accrued
ContingentMilestonesOrCoMarketingCommitmentsAccrued
0
CY2019Q3 svra Prepaid Research And Development Tax Credit Receivable
PrepaidResearchAndDevelopmentTaxCreditReceivable
1140000
CY2018Q4 svra Prepaid Research And Development Tax Credit Receivable
PrepaidResearchAndDevelopmentTaxCreditReceivable
1263000
CY2019Q3 svra Prepaid Contracted Research And Development Costs
PrepaidContractedResearchAndDevelopmentCosts
319000
CY2018Q4 svra Prepaid Contracted Research And Development Costs
PrepaidContractedResearchAndDevelopmentCosts
561000
CY2019Q3 us-gaap Value Added Tax Receivable Current
ValueAddedTaxReceivableCurrent
265000
CY2018Q4 us-gaap Value Added Tax Receivable Current
ValueAddedTaxReceivableCurrent
421000
CY2019Q3 us-gaap Prepaid Insurance
PrepaidInsurance
74000
CY2018Q4 us-gaap Prepaid Insurance
PrepaidInsurance
162000
CY2019Q3 svra Accrued Compensation
AccruedCompensation
1177000
CY2018Q4 svra Accrued Compensation
AccruedCompensation
643000
CY2019Q3 svra Foreign Currency Exchange Derivative
ForeignCurrencyExchangeDerivative
136000
CY2018Q4 svra Foreign Currency Exchange Derivative
ForeignCurrencyExchangeDerivative
26000
CY2018Q4 us-gaap Deferred Revenue
DeferredRevenue
250000
CY2019Q3 svra Accrued Lease Liability
AccruedLeaseLiability
564000
CY2018Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
41000
CY2019Q3 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
88393000
CY2018Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
86559000
CY2019Q3 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
103000
CY2018Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
30000
CY2019Q3 us-gaap Available For Sale Securities
AvailableForSaleSecurities
88496000
CY2018Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
86529000
us-gaap Available For Sale Securities Gross Realized Gain Loss Net
AvailableForSaleSecuritiesGrossRealizedGainLossNet
0
us-gaap Available For Sale Securities Gross Realized Gain Loss Net
AvailableForSaleSecuritiesGrossRealizedGainLossNet
0
CY2017Q2 svra Debt Instrument Prepayment Fee Percentage
DebtInstrumentPrepaymentFeePercentage
0.060
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
400000
CY2019Q3 svra Principal Payments Of Debt And End Of Term Charge Non Current
PrincipalPaymentsOfDebtAndEndOfTermChargeNonCurrent
25341000
CY2019Q3 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
202000
CY2019Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
177000
CY2019Q3 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2018Q4 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2019Q3 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2018Q4 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
CY2018 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
0
CY2018 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
0
CY2019Q3 svra Common Stock And Preferred Stock Shares Authorized
CommonStockAndPreferredStockSharesAuthorized
201000000
CY2019Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2019Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2019Q3 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
5020320
CY2018Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
4910016
CY2019Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
1644035
CY2017Q4 svra Lease Commencement Date
LeaseCommencementDate
2018-01-01
CY2017Q4 us-gaap Lease Expiration Date1
LeaseExpirationDate1
2021-07-31
CY2017Q4 us-gaap Operating Leases Rent Expense Minimum Rentals
OperatingLeasesRentExpenseMinimumRentals
200000
svra Lease Commencement Date
LeaseCommencementDate
2018-11-01
us-gaap Lease Expiration Date1
LeaseExpirationDate1
2022-09-30
us-gaap Operating Leases Rent Expense Minimum Rentals
OperatingLeasesRentExpenseMinimumRentals
100000
CY2019Q3 svra Lease Rental Payments Percentage
LeaseRentalPaymentsPercentage
0.02
CY2017Q1 svra Operating Lease Office Space
OperatingLeaseOfficeSpace
13707
CY2017Q1 svra Lease Commencement Date
LeaseCommencementDate
2017-07-01
CY2017Q1 us-gaap Lease Expiration Date1
LeaseExpirationDate1
2020-05-31
CY2017Q1 svra Lease Agreement Date
LeaseAgreementDate
2014-06-19
us-gaap Operating Leases Rent Expense Sublease Rentals1
OperatingLeasesRentExpenseSubleaseRentals1
500000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
200000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
478000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
184000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
67000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
929000
CY2019Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
57000
CY2019Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
872000
CY2019Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
376000
us-gaap Operating Lease Cost
OperatingLeaseCost
1117000
CY2019Q3 us-gaap Sublease Income
SubleaseIncome
153000
us-gaap Sublease Income
SubleaseIncome
461000
CY2019Q3 us-gaap Lease Cost
LeaseCost
223000
us-gaap Lease Cost
LeaseCost
656000
CY2019Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
198000
us-gaap Operating Lease Payments
OperatingLeasePayments
587000
CY2019Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P23M24D
CY2019Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.085
CY2019Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
800000
CY2019Q3 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
us-gaap:OtherAssetsNoncurrent
CY2019Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
600000
CY2019Q3 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
us-gaap:AccruedLiabilitiesCurrent
CY2019Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
300000
CY2019Q3 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
us-gaap:LiabilitiesOtherThanLongtermDebtNoncurrent
svra Employment Agreement Description
EmploymentAgreementDescription
Upon termination without cause, and not as a result of death or disability or resignation for good reason, each of such officers is entitled to receive a payment of base salary for twelve months and a pro-rated portion of their unpaid bonus following termination of employment, and such officer will be entitled to continue to receive coverage under medical and dental benefit plans for twelve months or until such officer is covered under a separate plan from another employer. Upon a termination other than for cause or resignation for good reason within twelve months following a change in control, each of such officers is entitled to receive a payment of base salary for eighteen months and one-hundred percent of their unpaid bonus following termination of employment and such officer will be entitled to continue to receive coverage under medical and dental benefit plans for twelve months or until such officer is covered under a separate plan from another employer and will also be entitled to certain acceleration of such officer’s outstanding nonvested options at the time of such termination.
svra Percentage Of Unpaid Bonus To Be Paid Upon Termination
PercentageOfUnpaidBonusToBePaidUponTermination
1.00
CY2019Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1146000
CY2018Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1988000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3292000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2792000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4245320
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3697887
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-51002000
CY2019Q3 svra Undistributed Earnings And Net Income Loss Attributable To Common Stockholders Basic And Diluted
UndistributedEarningsAndNetIncomeLossAttributableToCommonStockholdersBasicAndDiluted
-12403000
CY2018Q3 svra Undistributed Earnings And Net Income Loss Attributable To Common Stockholders Basic And Diluted
UndistributedEarningsAndNetIncomeLossAttributableToCommonStockholdersBasicAndDiluted
-12560000
svra Undistributed Earnings And Net Income Loss Attributable To Common Stockholders Basic And Diluted
UndistributedEarningsAndNetIncomeLossAttributableToCommonStockholdersBasicAndDiluted
-46454000
svra Undistributed Earnings And Net Income Loss Attributable To Common Stockholders Basic And Diluted
UndistributedEarningsAndNetIncomeLossAttributableToCommonStockholdersBasicAndDiluted
-51002000

Files In Submission

Name View Source Status
0001564590-19-041725-index-headers.html Edgar Link pending
0001564590-19-041725-index.html Edgar Link pending
0001564590-19-041725.txt Edgar Link pending
0001564590-19-041725-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
svra-10q_20190930.htm Edgar Link pending
svra-20190930.xml Edgar Link completed
svra-20190930.xsd Edgar Link pending
svra-20190930_cal.xml Edgar Link unprocessable
svra-20190930_def.xml Edgar Link unprocessable
svra-20190930_lab.xml Edgar Link unprocessable
svra-20190930_pre.xml Edgar Link unprocessable
svra-ex311_6.htm Edgar Link pending
svra-ex312_9.htm Edgar Link pending
svra-ex321_7.htm Edgar Link pending